EcoDrugPlus

Integrin Subunit Alpha 4

Ensembl ID : ENSPEMG00000013847
Gene Symbol: ITGA4
3 Cross references
236 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSPEMG00000011120
Gene Symbol: ITGB1
3 Cross references
298 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSPEMG00000007846
Gene Symbol: ITGB3
3 Cross references
265 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSPEMG00000016525
Gene Symbol: ITGB5
3 Cross references
210 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSPEMG00000013549
Gene Symbol: ITGB6
3 Cross references
206 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSPEMG00000021722
Gene Symbol: ITGB8
3 Cross references
202 Possible Orthologues:

Intercellular Adhesion Molecule 1

Ensembl ID : ENSPEMG00000024025
Gene Symbol: ICAM1
1 Cross references
93 Possible Orthologues:

Interleukin 5

Ensembl ID : ENSPEMG00000008086
Gene Symbol: IL5
3 Cross references
91 Possible Orthologues:

Interleukin 6

Ensembl ID : ENSPEMG00000020620
Gene Symbol: IL6
3 Cross references
162 Possible Orthologues:

Interleukin-1 Receptor-Associated Kinase 4

Ensembl ID : ENSPEMG00000018737
Gene Symbol: IRAK4
1 Cross references
202 Possible Orthologues:

Interstitial Collagenase A-Like

Ensembl ID : ENSPEMG00000020690
Gene Symbol: LOC102906935
2 Cross references
352 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSPEMG00000016518
Gene Symbol: IDH1
3 Cross references
232 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).